TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 9,624 | $722K |
| Grant or award | 6 | 235,563 | |
| Option exercise | 2 | 38,570 | |
| Bona-fide gift | 1 | 18,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
36 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Tamer I. Khayal - Officer | Option exercise | Common Stock | 1,084 | $13.28 | $14K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 1,084 | $86.40 | $94K | |
| Tamer I. Khayal - Officer | Option exercise | Stock Option (Right to Buy) | 1,084 | $0.00 | - | |
| Tamer I. Khayal - Officer | Option exercise | Common Stock | 1,458 | $38.46 | $56K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 1,458 | $90.04 | $131K | |
| Tamer I. Khayal - Officer | Option exercise | Stock Option (Right to Buy) | 1,458 | $0.00 | - | |
| Edward M. Basile | Option exercise | Common Stock | 6,750 | $28.12 | $190K | |
| Edward M. Basile | Open-market sale | Common Stock | 5,296 | $83.35 | $441K | |
| Edward M. Basile | Open-market sale | Common Stock | 1,454 | $84.30 | $123K | |
| Edward M. Basile | Option exercise | Stock Option (Right to Buy) | 6,750 | $0.00 | - | |
| Tamer I. Khayal - Officer | Option exercise | Common Stock | 1,083 | $13.28 | $14K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 1,083 | $82.64 | $89K | |
| Tamer I. Khayal - Officer | Option exercise | Stock Option (Right to Buy) | 1,083 | $0.00 | - | |
| Option exercise | Common Stock | 8,625 | $13.28 | $115K | ||
| Open-market sale | Common Stock | 3,607 | $131.91 | $476K | ||
| Open-market sale | Common Stock | 3,518 | $132.82 | $467K | ||
| Open-market sale | Common Stock | 1,200 | $134.23 | $161K | ||
| Open-market sale | Common Stock | 300 | $135.04 | $41K | ||
| Option exercise | Stock Option (Right to Buy) | 8,625 | $0.00 | - | ||
| Tamer I. Khayal - Officer | Option exercise | Common Stock | 1,458 | $38.46 | $56K | |
| Tamer I. Khayal - Officer | Option exercise | Common Stock | 417 | $66.10 | $28K | |
| Tamer I. Khayal - Officer | Option exercise | Common Stock | 1,083 | $13.28 | $14K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 823 | $146.15 | $120K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 900 | $146.90 | $132K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 80 | $147.98 | $12K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 523 | $149.59 | $78K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 318 | $150.38 | $48K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 80 | $151.20 | $12K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 80 | $152.28 | $12K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 20 | $153.75 | $3K | |
| Tamer I. Khayal - Officer | Open-market sale | Common Stock | 134 | $154.86 | $21K | |
| Tamer I. Khayal - Officer | Option exercise | Stock Option (Right to Buy) | 1,458 | $0.00 | - | |
| Tamer I. Khayal - Officer | Option exercise | Stock Option (Right to Buy) | 417 | $0.00 | - | |
| Tamer I. Khayal - Officer | Option exercise | Stock Option (Right to Buy) | 1,083 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 36 TMDX filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
TransMedics Group, Inc. (TMDX) had 5 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for TMDX runs to 36 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TMDX were filed in the last 90 days. 4 purchases are on record for this company.
1 insider sale of TMDX was filed in the last 90 days, totaling $722K.
This page tracks TMDX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TMDX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.